• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测氯吡格雷抵抗的新型多重 HRM 分析方法。

A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance.

机构信息

School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200127, P.R. China.

Department of Laboratory Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, P.R. China.

出版信息

Sci Rep. 2017 Nov 22;7(1):16021. doi: 10.1038/s41598-017-16310-8.

DOI:10.1038/s41598-017-16310-8
PMID:29167499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5700108/
Abstract

Clopidogrel is an antiplatelet medicine used to prevent blood clots in patients who have had a heart attack, stroke, or other symptoms. Variability in the clinical response to clopidogrel treatment has been attributed to genetic factors. In particular, five SNPs of rs4244285, rs4986893, rs12248560, rs662 and rs1045642 have been associated with resistance to clopidogrel therapy in Chinese population. This work involves the development of a multiplex high-resolution melting (HRM) assay to genotype all five of these loci in 2 tubes. Amplicons corresponding to distinct SNPs in a common tube were designed with the aid of uMelt prediction software to have different melting temperatures Tm by addition of a GC-rich tail to the 5' end of the certain primers. Two kinds of commercial methods, Digital Fluorescence Molecular Hybridization (DFMH) and Sanger sequencing, were used as a control. Three hundred sixteen DFMH pretested samples from consecutive acute coronary syndrome patients were used for a blinded study of multiplex HRM. The sensitivity of HRM was 100% and the specificity was 99.93% reflecting detection of variants other than the known resistance SNPs. Multiplex HRM is an effective closed-tube, highly accurate, fast, and inexpensive method for genotyping the 5 clopidogrel resistance associated SNPs.

摘要

氯吡格雷是一种抗血小板药物,用于预防心脏病发作、中风或其他症状的患者发生血栓。氯吡格雷治疗的临床反应存在变异性,这归因于遗传因素。特别是,rs4244285、rs4986893、rs12248560、rs662 和 rs1045642 这五个 SNP 与中国人群对氯吡格雷治疗的耐药性有关。这项工作涉及开发一种多重高分辨率熔解(HRM)分析方法,在 2 个管中对所有 5 个基因座进行基因分型。在 uMelt 预测软件的辅助下,设计了对应于同一管中不同 SNP 的扩增子,通过在特定引物的 5' 端添加富含 GC 的尾巴,使它们具有不同的熔解温度 Tm。使用两种商业方法,数字荧光分子杂交(DFMH)和 Sanger 测序,作为对照。对 316 例来自连续急性冠脉综合征患者的 DFMH 预测试样本进行了多重 HRM 盲法研究。HRM 的灵敏度为 100%,特异性为 99.93%,反映了除已知耐药 SNP 以外的变异体的检测。多重 HRM 是一种有效的闭管、高度准确、快速且廉价的方法,可用于对 5 个与氯吡格雷耐药相关的 SNP 进行基因分型。

相似文献

1
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance.一种用于检测氯吡格雷抵抗的新型多重 HRM 分析方法。
Sci Rep. 2017 Nov 22;7(1):16021. doi: 10.1038/s41598-017-16310-8.
2
Comparison of high-resolution melting analysis, TaqMan Allelic discrimination assay, and sanger sequencing for Clopidogrel efficacy genotyping in routine molecular diagnostics.用于常规分子诊断的氯吡格雷疗效基因分型的高分辨率熔解分析、TaqMan 等位基因鉴别分析和 Sanger 测序比较。
J Mol Diagn. 2013 Sep;15(5):600-6. doi: 10.1016/j.jmoldx.2013.04.005. Epub 2013 Jun 28.
3
Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.氯吡格雷治疗的中国患者中治疗时血小板高反应性的遗传决定因素。
Thromb Res. 2013 Jul;132(1):81-7. doi: 10.1016/j.thromres.2013.05.006. Epub 2013 May 29.
4
Genotyping SNPs and Indels: A method to improve the scope and sensitivity of High-Resolution melt (HRM) analysis based applications.基因分型 SNPs 和 Indels:一种提高高分辨率熔解(HRM)分析应用的范围和灵敏度的方法。
Clin Chim Acta. 2024 Aug 15;562:119897. doi: 10.1016/j.cca.2024.119897. Epub 2024 Aug 2.
5
CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.CRISPLD1 rs12115090 多态性改变了汉族冠心病患者氯吡格雷的抗血小板作用。
Gene. 2018 Dec 15;678:226-232. doi: 10.1016/j.gene.2018.08.027. Epub 2018 Aug 7.
6
Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel.开发一种针对抗血小板药物氯吡格雷的多重且具成本效益的基因检测方法,以实现更个性化的药物治疗。
Int J Mol Sci. 2014 May 5;15(5):7699-710. doi: 10.3390/ijms15057699.
7
Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.在中国经皮冠状动脉介入治疗后的患者群体中,PEAR1基因变异与阿司匹林和氯吡格雷双重抗血小板治疗反应中血小板反应性的关联。
Thromb Res. 2016 May;141:28-34. doi: 10.1016/j.thromres.2016.02.031. Epub 2016 Mar 2.
8
[Duplex genotyping of CYP2C19*2 and CYP2C19*3 by high-resolution melting curve analysis].通过高分辨率熔解曲线分析对CYP2C19*2和CYP2C19*3进行双重基因分型
Yi Chuan. 2013 Jul;35(7):923-30. doi: 10.3724/sp.j.1005.2013.00923.
9
Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy.接受氯吡格雷治疗的中国冠心病患者高血小板反应性的基因多态性
Int J Clin Pharm. 2020 Feb;42(1):158-166. doi: 10.1007/s11096-019-00953-w. Epub 2020 Apr 6.
10
The Frequency of the Minor Polymorphisms in the , Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome.俄罗斯和布里亚特急性冠状动脉综合征患者中 基因的次要多态性频率及其与临床结局的关系。
Genet Test Mol Biomarkers. 2020 Jun;24(6):338-342. doi: 10.1089/gtmb.2019.0216. Epub 2020 May 11.

引用本文的文献

1
The Impact of SNP Score on Low-Density Lipoprotein Cholesterol Concentration and Coronary Artery Disease.单核苷酸多态性评分对低密度脂蛋白胆固醇浓度及冠状动脉疾病的影响
Int J Mol Sci. 2025 Mar 6;26(5):2337. doi: 10.3390/ijms26052337.
2
Monitoring of pyrethroid resistance in Aedes aegypti: first report of double and triple kdr mutations in Buenos Aires Province.监测埃及伊蚊对拟除虫菊酯类杀虫剂的抗性:布宜诺斯艾利斯省首次发现双和三重 kdr 突变。
Parasit Vectors. 2024 Nov 9;17(1):458. doi: 10.1186/s13071-024-06547-4.
3
Clopidogrel Resistance in Ischemic Stroke Patients.

本文引用的文献

1
Rapid Genotyping of Shigella sonnei by Use of Multiplex High-Resolution Melting.使用多重高分辨率熔解技术对宋内志贺菌进行快速基因分型
J Clin Microbiol. 2015 Jul;53(7):2389-91. doi: 10.1128/JCM.00874-15. Epub 2015 Apr 29.
2
VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke.中国非心源性缺血性卒中患者中血管舒张刺激磷蛋白磷酸化与氯吡格雷抵抗的基因多态性
Thromb Res. 2014 Dec;134(6):1272-7. doi: 10.1016/j.thromres.2014.10.001. Epub 2014 Oct 12.
3
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.
缺血性中风患者的氯吡格雷抵抗
Ann Indian Acad Neurol. 2024 Sep 1;27(5):493-497. doi: 10.4103/aian.aian_79_24. Epub 2024 Jul 24.
4
First report on knockdown resistance mutations in wild populations of Aedes aegypti from Argentina determined by a novel multiplex high-resolution melting polymerase chain reaction method.阿根廷野生埃及伊蚊种群中击倒抗性突变的首次报告,采用新型多重高分辨率熔解聚合酶链反应方法确定。
Parasit Vectors. 2023 Jul 6;16(1):222. doi: 10.1186/s13071-023-05840-y.
5
Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.伴有心房颤动和植入新一代药物洗脱支架的急性冠状动脉综合征患者的最佳抗血栓治疗的理由和设计:新型抗血栓药物(OPTIMA)-4 试验。
Clin Cardiol. 2023 Jul;46(7):777-784. doi: 10.1002/clc.24025. Epub 2023 May 16.
6
Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study.MTHFR C677T 多态性与无幽门螺杆菌感染的慢性萎缩性胃炎患者严重程度和定位的相关性:一项病例对照研究。
BMC Cancer. 2020 Aug 5;20(1):725. doi: 10.1186/s12885-020-07208-2.
7
Development and validation of T-ARMS-PCR to detect CYP2C19*17 allele.开发和验证 T-ARMS-PCR 检测 CYP2C19*17 等位基因。
J Clin Lab Anal. 2020 Jan;34(1):e23005. doi: 10.1002/jcla.23005. Epub 2019 Aug 22.
ST段抬高型心肌梗死患者中CYP2C19基因分型指导的抗血小板治疗——直接经皮冠状动脉介入治疗(POPular)遗传学研究的原理与设计
Am Heart J. 2014 Jul;168(1):16-22.e1. doi: 10.1016/j.ahj.2014.03.006. Epub 2014 Mar 21.
4
An allele-specific PCR system for rapid detection and discrimination of the CYP2C19∗4A, ∗4B, and ∗17 alleles: implications for clopidogrel response testing.一种用于快速检测和区分 CYP2C19∗4A、∗4B 和∗17 等位基因的等位基因特异性 PCR 系统:对氯吡格雷反应测试的影响。
J Mol Diagn. 2013 Nov;15(6):783-9. doi: 10.1016/j.jmoldx.2013.06.004. Epub 2013 Sep 5.
5
Comparison of high-resolution melting analysis, TaqMan Allelic discrimination assay, and sanger sequencing for Clopidogrel efficacy genotyping in routine molecular diagnostics.用于常规分子诊断的氯吡格雷疗效基因分型的高分辨率熔解分析、TaqMan 等位基因鉴别分析和 Sanger 测序比较。
J Mol Diagn. 2013 Sep;15(5):600-6. doi: 10.1016/j.jmoldx.2013.04.005. Epub 2013 Jun 28.
6
Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivity.基于微阵列的即时 CYP2C19 基因分型检测预测氯吡格雷治疗中的血小板反应性的可行性。
Biomed Res Int. 2013;2013:154073. doi: 10.1155/2013/154073. Epub 2013 Mar 28.
7
Symmetric snapback primers for scanning and genotyping of the cystic fibrosis transmembrane conductance regulator gene.用于囊性纤维化跨膜电导调节因子基因扫描和基因分型的对称回拉引物。
Clin Chem. 2013 Jul;59(7):1052-61. doi: 10.1373/clinchem.2013.202689. Epub 2013 Mar 15.
8
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function.尽管排除或控制了基因多态性(CYP2C19、ABCB1、PON1)、不依从性、饮食、吸烟、合并用药(包括质子泵抑制剂)以及血小板功能的固有变异性,氯吡格雷的药代动力学和药效学仍存在广泛差异。
J Am Coll Cardiol. 2013 Feb 26;61(8):872-9. doi: 10.1016/j.jacc.2012.11.040. Epub 2013 Jan 16.
9
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.即时检测指导抗血小板治疗个体化的研究(RAPID GENE):一项前瞻性、随机、概念验证试验。
Lancet. 2012 May 5;379(9827):1705-11. doi: 10.1016/S0140-6736(12)60161-5. Epub 2012 Mar 29.
10
Value of CYP2C19 *2 and *17 genotyping in clinical practice. Promising but not ready yet.CYP2C19 *2和*17基因分型在临床实践中的价值。前景光明但尚未成熟。
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):205-7. doi: 10.1016/j.recesp.2011.09.024. Epub 2012 Jan 28.